Efficacy, Feasibility, and Acceptability of the DeST-ACT: Trauma-Focused Acceptance and Commitment Therapy Program

Launched by CANSAGLIGI FOUNDATION · May 21, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new therapy program called DeST-ACT, designed to help people who experienced trauma from the recent earthquake. The program focuses on Acceptance and Commitment Therapy (ACT), which helps individuals manage their thoughts and feelings while working towards a fulfilling life. The researchers want to see if this program can improve life satisfaction and help people feel more flexible in dealing with their emotions after such a traumatic event.

To participate in this study, you need to have been in one of the cities affected by the earthquake on February 6, such as Kahramanmaras or Gaziantep, and you must be willing to take part in online interviews with a therapist. You should also be able to read and understand instructions. People who have certain severe mental health conditions or who are currently changing their psychiatric treatment are not eligible to join. This trial is not yet recruiting participants, but it aims to find out how effective and acceptable this therapy program is for those affected by the earthquake.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Volunteering to participate in the research
• • Being present in cities such as Kahramanmaras, Gaziantep, Hatay, Adiyaman, or Malatya during the earthquake on February 6, where destruction occurred
• • Being literate
• • Being able to have an online interview with the therapist
• • Having sub-threshold PTSD or PTSD
• Exclusion Criteria:
• • Being in other cities at the time of the earthquake and not being exposed to the earthquake
• • Having visual and/or hearing problems
• • Having any psychotic disorder, experiencing an active mood episode, or having conditions such as intellectual disability or dementia that would prevent participation in therapy
• • Starting a new psychiatric treatment during the research period or having a change in medication or dosage within the last 3 months.